Obesity Drug Makers Expand Testing to Children as Young as 6
Source Summary
Multiple obesity drugmakers are conducting clinical trials in children as young as 6 years old. The article also covers other biotech developments including Vera's kidney drug approval efforts and early data from Syntis Bio.
Why it matters
Pediatric obesity drug trials represent an expansion of treatment options for childhood obesity, a growing public health concern.
